Monitoring methods and devices for use therein

• US 6,451,619 B1
• Filed: 09/22/1995
• Issued: 09/17/2002
• Est. Priority Date: 06/29/1994
• Status: Expired due to Term

• Current Assignee: Inverness Medical Switzerland GmbH (Abbott Laboratories Incorporated)
• Original Assignee: Inverness Medical Switzerland GmbH (Abbott Laboratories Incorporated)
• Inventors: Wilson, Stewart, Prior, Michael E, Zhang, Zhi G, Mundill, Paul HC, Catt, Michael, Cunningham, Carole R
• Primary Examiner(s): Graser, Jennifer E.
• Application Number:
  US08/532,457
• Time in Patent Office: 2,552 Days
• Field of Search: 436/514, 436/165, 436/169, 436/65, 435/7.92, 435/7.93, 435/7.94, 435/7.9, 435/7.1, 422/56, 422/58, 422/61
• US Class Current: 436/514
• CPC Class Codes: A61B 10/0012 Ovulation-period determination for animals A61D17/002
• CPC Class Codes: A61D 17/002 for detecting period of heat of animals, i.e. for detecting oestrus for humans A61B10/0012
• CPC Class Codes: B01L 2200/12 Specific details about manufacturing devices
• CPC Class Codes: B01L 2400/0406 capillary forces

Abstract

Methods, devices and test kits for monitoring the ovulation cycle, involve testing the body fluid, e.g. urinary, concentration of one or more analytes. Preferably estrone-3-glucuronide and luteinizing hormone are both measured, and a reference concentration for E3G is established at about day 6 of the current cycle. Preferably, disposable testing devices are used, in conjunction with a relatively permanent electronic reader/monitor. The number of “daily” tests required per month can be minimized.

Claims

1. A test kit for use in monitoring an ovulation cycle of a female mammal, which kit consists essentially of a plurality of disposable testing devices for sampling and testing a body fluid, and providing readable signals indicative of the concentrations of at least two different analytes in said body fluid, together with an electronic reader/monitor for reading and interpreting said readable signals to provide the user with an indication of the fertility status of said cycle, wherein:

a) said readable signals are read while one of said testing devices is located within a receiving means of said reader/monitor;

b) said readable signals are created by concentrating a first detectable material in a first detection zone of a porous carrier within said testing device and by concentrating a second detectable material in a second detection zone of said porous carrier, while said sampled body fluid is flowing through said porous carrier, wherein said flowing body fluid contacts said first detection zone and said second detection zone sequentially;

c) said first detection zone signal being the result of a sandwich-format specific binding reaction and thereby being directly indicative of the body fluid concentration of a first analyte which first analyte exhibits a detectable concentration change closely associated with the time of actual ovulation;

d) said second detection zone signal being the result of a competition-format specific binding reaction and thereby is indicative of the body fluid concentration of a second analyte, which second analyte exhibits a detectable concentration change after menses but in advance of the time of actual ovulation;

e) said second detection zone being downstream from said first detection zone relative to a receiving portion of said testing device which is contacted with said body fluid to initiate said tests, said first detection zone containing an immobilized anti-LH antibody and said second detection zone containing immobilized hapten or an analog thereof;

f) said readable signals are read by optical transmission through said testing device using pulsed diffuse light; and

g) the reader/monitor comprising;

(1) a source of pulsed diffuse light having a wavelength that is strongly absorbed by said detectable materials;

(2) a sensing means for sensing incident light from said source;

(3) a receiving means for receiving and holding said testing device with each of said detection zones in a light path between said source and said sensor; and

(4) an electronic means for deriving detectable material concentration, said electronic means being connected to said sensing means, said electronic means being programmed to derive from sensed incident light a measure of the extend to which detectable material has become concentrated in each of said detection zones.

2. A test kit according to claim 1 for use in monitoring the human ovulation cycle.

3. A test kit according to claim 2 wherein the body fluid is urine.

4. A test kit according to claim 1, wherein said diffuse light is pulsed, and said electronic means is programmed to control said sensing means such that said sensing means only senses incident light in phase with said pulsed light, said light preferably having a pulse frequency of at least about 1 kHz.

5. A test kit as claimed in claim 1, wherein said receiving means incorporates interlocking means engagable with corresponding interlocking means on said testing device to ensure that upon receipt of said testing device by said reader/monitor said detection zones are located and maintained in a predetermined spacial relationship relative to said sensing means.

6. A test kit as claimed in claim 5, wherein said receiving means includes actuating means triggered by said receipt of said testing device, said actuating means causing said reading of said detection zones to be initiated.

7. A test kit as claimed in claim 5, wherein said testing device has a casing or cover which includes internal registration means which engages with corresponding registration means associated with porous said carrier such that said detection zones within said testing device casing or cover are located in a predetermined spacial relationship relative to said interlocking means on said testing device casing or cover.

8. A test kit according to claim 6, wherein said internal registration means comprises a pin, engagable with a hole or indentation in said porous carrier, said detection zones being at predetermined locations on said porous carrier relative to said hole or indentation.

9. A test kit according to claim 1, wherein said readable signals are created by concentrating particle-labelled reagents in the respective detection zones.

10. A test kit according to claim 1, containing a sufficient plurality of disposable testing devices to enable a user to conduct testing on a one-per-day basis for a maximum of 16 days in any one ovulation cycle.

11. A replacement pack containing from about 7 about 12 disposable testing devices to replenish a test kit according to claim 1, plus instructions to the user to use all of said testing devices during the course of one ovulation cycle.